DK1485363T3 - Cykliske amider - Google Patents
Cykliske amiderInfo
- Publication number
- DK1485363T3 DK1485363T3 DK03708178T DK03708178T DK1485363T3 DK 1485363 T3 DK1485363 T3 DK 1485363T3 DK 03708178 T DK03708178 T DK 03708178T DK 03708178 T DK03708178 T DK 03708178T DK 1485363 T3 DK1485363 T3 DK 1485363T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclic amides
- psychoses
- schizophrenia
- huntington
- epilepsy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10210779A DE10210779A1 (de) | 2002-03-12 | 2002-03-12 | Cyclische Amide |
| PCT/EP2003/002224 WO2003076420A1 (de) | 2002-03-12 | 2003-03-05 | Cyclische amide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1485363T3 true DK1485363T3 (da) | 2009-02-02 |
Family
ID=27797699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03708178T DK1485363T3 (da) | 2002-03-12 | 2003-03-05 | Cykliske amider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7816376B2 (da) |
| EP (1) | EP1485363B1 (da) |
| JP (1) | JP2005519953A (da) |
| CN (1) | CN1642927A (da) |
| AT (1) | ATE410418T1 (da) |
| AU (1) | AU2003212305B2 (da) |
| CA (1) | CA2478945A1 (da) |
| CY (1) | CY1108674T1 (da) |
| DE (2) | DE10210779A1 (da) |
| DK (1) | DK1485363T3 (da) |
| ES (1) | ES2315483T3 (da) |
| PL (1) | PL371215A1 (da) |
| PT (1) | PT1485363E (da) |
| RU (1) | RU2004130426A (da) |
| SI (1) | SI1485363T1 (da) |
| WO (1) | WO2003076420A1 (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05003632A (es) * | 2002-10-11 | 2005-06-03 | Astrazeneca Ab | Derivados de piperidina 1, 4-disustituidos y su uso como inhibidores de 11-beta-hidroesteroide deshidrogenasa humana de tipo 1 (11betahsd1). |
| ES2332597T3 (es) * | 2004-05-27 | 2010-02-09 | Ucb Pharma S.A. | Derivados de benzoxazolona, procedimientos para su preparacion y su uso. |
| MY148644A (en) | 2005-07-18 | 2013-05-15 | Orion Corp | New pharmaceutical compounds |
| EP2520567A3 (en) * | 2006-02-23 | 2012-12-12 | Shionogi & Co., Ltd. | Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| JPWO2009025265A1 (ja) * | 2007-08-21 | 2010-11-25 | 塩野義製薬株式会社 | ピペラジン誘導体 |
| MX2009014235A (es) | 2007-08-22 | 2010-04-27 | Abbott Gmbh & Co Kg | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. |
| EP2271625B1 (en) | 2008-04-01 | 2012-09-12 | Abbott GmbH & Co. KG | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| JP2012500801A (ja) * | 2008-08-21 | 2012-01-12 | リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ | Ｃｎｓ疾患の治療法 |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| TW201038569A (en) | 2009-02-16 | 2010-11-01 | Abbott Gmbh & Co Kg | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| BRPI1009800A2 (pt) * | 2009-04-02 | 2016-03-15 | Merck Patent Gmbh | compostos heterocíclicos como inibidores de autotaxina |
| US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| JP2014521682A (ja) | 2011-08-05 | 2014-08-28 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノクロマン、アミノチオクロマンおよびアミノ−１，２，３，４−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用 |
| US8846741B2 (en) | 2011-11-18 | 2014-09-30 | Abbvie Inc. | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| NZ701291A (en) * | 2012-05-21 | 2015-12-24 | Wolff August Gmbh & Co Kg Arzneimittel Dr | Novel 1,3-benzoxazol-2(3h)-ones and their use as medicaments and cosmetics |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CN104211635A (zh) * | 2013-06-03 | 2014-12-17 | 中国科学院上海药物研究所 | 一类哌啶类化合物及其制备方法、药物组合物和用途 |
| EP3057960B1 (en) | 2013-10-17 | 2019-02-27 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CA2924699A1 (en) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| DK288287A (da) | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
| US5036088A (en) * | 1986-06-09 | 1991-07-30 | Pfizer Inc. | Antiallergy and antiinflammatory agents, compositions and use |
| JPH0283376A (ja) * | 1988-09-19 | 1990-03-23 | Pfizer Pharmaceut Co Ltd | ベンゾオキサゾロン誘導体および抗アレルギー又は抗炎症組成物 |
| IL93473A0 (en) * | 1989-02-28 | 1990-11-29 | Pfizer | Antiinflammatory benzoxazolones |
| ATE174915T1 (de) * | 1994-10-31 | 1999-01-15 | Merck Patent Gmbh | Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren |
| JP2003535083A (ja) * | 2000-05-31 | 2003-11-25 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 二環式シクロヘキシルアミンおよびｎｍｄａ受容体アンタゴニストとしてのそれらの使用 |
| MXPA02010503A (es) * | 2000-06-06 | 2003-03-10 | Warner Lambert Co | Ciclohexilaminas biciclicas y su uso como antagonistas del receptor nmda. |
| ATE408611T1 (de) * | 2001-07-24 | 2008-10-15 | Richter Gedeon Nyrt | Piperidine als nmda-rezeptorantagonisten |
-
2002
- 2002-03-12 DE DE10210779A patent/DE10210779A1/de not_active Withdrawn
-
2003
- 2003-03-05 DK DK03708178T patent/DK1485363T3/da active
- 2003-03-05 DE DE50310609T patent/DE50310609D1/de not_active Expired - Lifetime
- 2003-03-05 CA CA002478945A patent/CA2478945A1/en not_active Abandoned
- 2003-03-05 EP EP03708178A patent/EP1485363B1/de not_active Expired - Lifetime
- 2003-03-05 AT AT03708178T patent/ATE410418T1/de not_active IP Right Cessation
- 2003-03-05 SI SI200331440T patent/SI1485363T1/sl unknown
- 2003-03-05 RU RU2004130426/04A patent/RU2004130426A/ru not_active Application Discontinuation
- 2003-03-05 ES ES03708178T patent/ES2315483T3/es not_active Expired - Lifetime
- 2003-03-05 JP JP2003574639A patent/JP2005519953A/ja active Pending
- 2003-03-05 AU AU2003212305A patent/AU2003212305B2/en not_active Ceased
- 2003-03-05 US US10/507,581 patent/US7816376B2/en not_active Expired - Fee Related
- 2003-03-05 PT PT03708178T patent/PT1485363E/pt unknown
- 2003-03-05 CN CNA038057905A patent/CN1642927A/zh active Pending
- 2003-03-05 PL PL03371215A patent/PL371215A1/xx unknown
- 2003-03-05 WO PCT/EP2003/002224 patent/WO2003076420A1/de active Application Filing
-
2008
- 2008-12-30 CY CY20081101501T patent/CY1108674T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1642927A (zh) | 2005-07-20 |
| CA2478945A1 (en) | 2003-09-18 |
| SI1485363T1 (sl) | 2009-02-28 |
| RU2004130426A (ru) | 2005-05-27 |
| ATE410418T1 (de) | 2008-10-15 |
| DE50310609D1 (de) | 2008-11-20 |
| US7816376B2 (en) | 2010-10-19 |
| US20050124627A1 (en) | 2005-06-09 |
| AU2003212305B2 (en) | 2009-04-23 |
| AU2003212305A1 (en) | 2003-09-22 |
| WO2003076420A1 (de) | 2003-09-18 |
| EP1485363B1 (de) | 2008-10-08 |
| DE10210779A1 (de) | 2003-10-09 |
| EP1485363A1 (de) | 2004-12-15 |
| PT1485363E (pt) | 2009-01-09 |
| PL371215A1 (en) | 2005-06-13 |
| JP2005519953A (ja) | 2005-07-07 |
| CY1108674T1 (el) | 2014-04-09 |
| ES2315483T3 (es) | 2009-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108674T1 (el) | Κυκλικα αμιδια | |
| AU2003224064A8 (en) | Substituted indoles | |
| MX2009011830A (es) | Compuestos amino-heterociclicos. | |
| TW200738666A (en) | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | |
| ATE463495T1 (de) | Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten | |
| MXPA06002296A (es) | Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos. | |
| NO20064726L (no) | Imidazolforbindelser for behandling av neurodegenerative forstyrrelser | |
| MY147390A (en) | Substituted isoindoles as bace inhibitors and their use | |
| MY149422A (en) | 5-(arylsulfonyl)-pyrazolopiperidines | |
| RS20060129A (en) | /1,8/naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| DE602004028150D1 (de) | Aminopyrazolderivate als gsk-3-inhibitoren | |
| ATE544744T1 (de) | Verfahren zur herstellung von benzoesaure derivaten | |
| RS108404A (en) | Diphenyl azetidinones substituted by acidic groups,method for their production,medicaments containing said compounds and use thereof | |
| IL165790A0 (en) | Cationically substituted diphenyl azetidinones method for their production medicaments containing said compounds and use thereof | |
| TW200602297A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
| NO20004668L (no) | 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister | |
| MY138547A (en) | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists | |
| UY27825A1 (es) | Derivados de n-acilamino bencil eter | |
| ATE524171T1 (de) | Verwendung von 2-(2-nitro-4- trifluormethylbenzoyl)-1,3-cyclohexandion bei der behandlung der parkinson-krankheit | |
| NO20063012L (no) | Fremgangsmaten for syntesen av perindopril og farmasoytisk akseptable salter derav | |
| MXPA06000416A (es) | Amidas azaheterociclicas novedosas utiles para tratar el dolor. | |
| IL184439A0 (en) | 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 | |
| DE602005012826D1 (de) | Neue mao-b-hemmer | |
| CY1114108T1 (el) | Αμινο-ετεροκυκλικες ενωσεις που χρησιμοποιουνται ως αναστολεις pde9 |